Rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF and Associated Factors Among Presumptive Pulmonary Tuberculosis Patients in Nepal.
Shiv Kumar SahPramod Raj BhattaraiAnjana ShresthaDeepak DhamiDeepa GuruwacharyaRenu ShresthaPublished in: Infection and drug resistance (2020)
The overall prevalence of MTB and RR-MTB was high in Nepalese study population, and that being previously treated with anti-TB drug remained significant predictors for MTB; proactive measures are urgently needed to address the challenge of prompt diagnosis, early management and improved monitoring of treatment to limit the emergence drug-resistant MTB strains in the community.
Keyphrases
- pulmonary tuberculosis
- mycobacterium tuberculosis
- drug resistant
- multidrug resistant
- end stage renal disease
- newly diagnosed
- acinetobacter baumannii
- healthcare
- chronic kidney disease
- escherichia coli
- ejection fraction
- mental health
- prognostic factors
- emergency department
- risk factors
- pseudomonas aeruginosa
- replacement therapy